SBIR reauthorization caps how many proposals one company can submit. How the new limits work and what it means for your 2026 strategy.
Most SBIR proposals get rejected on the first try. Here is how to use reviewer feedback to strengthen your resubmission and dramatically improve your odds.
SBIR proposals are reviewed by panels of technical experts. Here is what happens inside a review panel, how scores are assigned, and what separates funded proposals from rejections.
Your SAM.gov registration must be active before you can submit any SBIR proposal. Here is exactly how to register, renew, and avoid the delays that cause missed deadlines.
The Specific Aims page is the most important page of your NIH SBIR proposal. Here is the structure reviewers expect and how to write one that gets your proposal scored.
The new $30M Strategic Breakthrough Awards create a post-Phase II pathway for SBIR companies with commercial traction. Here is who qualifies, how matching works, and when to expect solicitations.
SBIR requires your company to perform at least two-thirds of Phase I work. Here is how the subcontracting rules work, how to calculate work percentages, and what happens when you exceed the limit.
SBIR success rates vary dramatically by agency — from 15% at NIH to over 25% at some DoD components. Here is the data and what it means for your submission strategy.
SBIR and STTR fund the same types of innovation but have different rules for university partnerships and work percentages. Here is how to choose the right program for your company.
STTR was designed to move university research into commercial products. Here is how academic researchers can use STTR to spin out their lab work and build a company.
Steel tariffs at 50%, China duties at 54%, and lab equipment costs surging across the board. For researchers already managing flat or shrinking grants, the tariff shock is forcing hard choices between personnel and reagents.
USDA funds SBIR proposals in precision agriculture, food safety, rural broadband, and sustainable farming. Here are the topic areas and how to apply.
The Department of Energy Early Career Research Program is accepting applications across seven scientific disciplines, with five-year awards up to $2.75 million. A strategy guide for researchers racing the March 24 pre-application deadline.
A joint HHS, USDA, and EPA initiative is channeling over $1 billion into regenerative farming, pesticide alternatives, and food safety research under the MAHA Commission. Here is what the funding looks like and who can access it.
The Trump administration designated Anthropic a supply chain risk after the company refused to remove AI safety restrictions. The fallout will reshape defense AI contracting for years.
ARPA-H is funding the first agentic AI system that can prescribe medications, monitor patients 24/7, and manage heart disease autonomously. Here is what applicants need to know.
After BRIC was cancelled and billions in IRA climate funds were frozen, communities need a new playbook. A strategic guide to surviving programs, state alternatives, and emerging funding sources.
The Department of Energy has nearly $1 billion in active funding for critical mineral processing, rare earth extraction, and battery material recycling. A strategic guide for applicants.
Harvard owes $368 million. Yale is cutting doctoral admissions by 13%. And every Ivy League school just hit record lobbying spending. The endowment tax is reshaping the research pipeline in real time.
The OMAI project — led by AI2, funded by NSF and NVIDIA — will create fully open multimodal AI models for scientific research. For researchers priced out of commercial AI, this changes the equation.
February 2026 saw $195B+ in private AI investment. The gap between corporate AI spending and public research funding has never been wider — and it is reshaping who gets to do science.
The Department of Government Efficiency has canceled $49 billion in federal grants across every major agency. An analysis of which programs were hit, why, and what nonprofits and research institutions must do now to survive the disruption.
DAF assets grew 27.5% to $326 billion in 2024 while federal grants collapsed. Here is how nonprofits can build a deliberate strategy to tap the largest and fastest-growing pool of philanthropic capital in America.
The FTA All Stations Accessibility Program has $686M for elevator retrofits, platform rebuilds, and ADA compliance at legacy transit stations. Applications close May 1.
The NSF NQNI program will fund up to 16 open-access quantum and nanotechnology research sites at $2M/year each. Letters of intent are due March 16.
SBIR/STTR reauthorized through 2031 — agencies are racing to release solicitations. Step-by-step guide to positioning your company for the first post-restart funding cycle.
The REAP program that funded 19,000+ clean energy projects for farmers and rural businesses has been frozen and its solar policy rewritten. A full analysis of what still works, what changed, and how to position for the next window.
Congress rejected proposed 40-50% cuts across NIH, NSF, NASA, DOE, and NOAA. Here is the full agency-by-agency breakdown and what it means for your next grant application.
The executive branch tried to cap university research overhead at 15%. Courts blocked it. Congress blocked it. The DOE implemented it anyway. Here is the full story and what it means for every institution that depends on federal grants.
The most bipartisan space bill in years creates new commercial research programs, codifies lunar outpost goals, and opens pathways for researchers who have never worked with NASA.
NSF is offering $10-50M annually to independent research teams outside academia and industry. This radical new funding model changes who can compete for federal science dollars.
SBIR/STTR reauthorized through 2031 with $30M Strategic Breakthrough Awards, proposal caps, and mandatory foreign risk screening. Full breakdown of every change affecting applicants.
Stephen Schwarzman plans to channel his $48B fortune into a mega-foundation focused on AI and education. Here is what grant seekers should know about the coming shift in philanthropic capital.
New data reveals AI-drafted grant proposals have higher NIH success rates but lower novelty scores. Combined with the six-application annual cap and AI ban, the landscape for researchers is shifting fast.
The BIOSECURE Act restricts federal grants and contracts involving Chinese biotech firms. For university labs, pharma companies, and federally funded researchers, the compliance clock is ticking.
The Department of Energy Office of Science FY2026 solicitation covers everything from fusion energy to biological research. A strategic guide to the largest open-ended federal science funding opportunity of the year.